Dexcom Inc (DXCM)

$111.66 0.00 (0.00%)

16:00 EDT DXCM Stock Quote Delayed 30 Minutes

3 Breakthrough Medical Device Stocks to Invest In Now

By Muslim Farooque, InvestorPlace Contributor Jul 8, 2024

Uncover the potential of leading medical device stocks boasting solid fundamentals and a promising future ahead.

Have $50K? 7 Stocks to Buy to Retire With $1 Million by 2034

Hype Hazards: 3 Stocks to Steer Clear of on Your Wealth-Building Journey

The 3 Best Diabetes Stocks to Buy in June 2024

Volume:

Previous Close -

Market Cap 10.80B

PE Ratio 72.51

EPS 1.54

Volume (Avg. Vol.) 7

Day's Range -

52-Week Range $74.75 - $142.00

Dividend & Yield N/A (N/A)

DXCM Stock Predictions, Articles, and Dexcom Inc News

The 3 Best MedTech Stocks to Buy Now: May 2024

By Shane Neagle, InvestorPlace Contributor May 29, 2024

Explore the best MedTech stocks to buy now that are driven by AI's potential to revolutionize healthcare efficiency.

3 Growth Stocks the New ‘GPT-4o’ AI Bot Says Will Make You Rich

By Omor Ibne Ehsan May 27, 2024

These three under-the-radar growth stocks picked by the new GPT-4o AI bot could deliver massive gains if the AI model is right.

Shhh! 3 Secret IoT Stocks Flying Below Wall Street’s Radar

By Michael Que, InvestorPlace Contributor May 3, 2024

The IoT industry is looking to continue growing strong, if you want high portfolio growth I recommend you buy these top three IoT stocks.

DXCM Stock Earnings: DexCom Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings Apr 25, 2024

DXCM stock results show that DexCom beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024

By Larry Ramer, InvestorPlace Contributor Apr 25, 2024

The medical device market is growing fast, and top medical device firms can become takeover targets. Here are three medtech stocks to watch.

Nasdaq Nightmares: 3 Stocks to Sell Before Reality Sets In

By Stavros Tousios, InvestorPlace Contributor Apr 10, 2024

DoorDash, DexCom, and Advanced Micro Devices are three Nasdaq stocks to sell before reality sets in as exuberance may be fading.

3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild

By Shane Neagle, InvestorPlace Contributor Apr 10, 2024

Discover top obesity drug stocks set to soar as demand surges. Eli Lilly, Novo Nordisk, & Dexcom lead with revolutionary treatments

7 Nasdaq Stocks to Sell in April Before They Crash & Burn

By Ian Bezek, InvestorPlace Contributor Apr 3, 2024

The momentum in growth companies is likely to run out. Move on from these Nasdaq stocks to sell in April before it's too late.

3 Overvalued S&P 500 Stocks for Your ‘Do NOT Buy’ List

By Will Ashworth, InvestorPlace Contributor Apr 1, 2024

The S&P 500’s current P/E ratio is 30% higher than a year ago, making it easier to find overvalued S&P 500 stocks to buy.

More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’

By Rich Duprey, InvestorPlace Contributor Mar 25, 2024

Investors should take notice of these stocks with high analyst ratings. It's time to load up your portfolio.

3 Telehealth Stocks With Room to Run in 2024

By Muslim Farooque, InvestorPlace Contributor Feb 29, 2024

Embrace 2024's leading telehealth stocks to buy, merging cutting-edge care with smart investing for a lucrative portfolio.

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution

By Alex Sirois, InvestorPlace Contributor Feb 14, 2024

Obesity drug sales boomed in 2023 and will continue in 2024 making these weight loss stocks attratcive considerations for pharma investors.

3 Mid-Cap Stocks Poised for a Breakout in 2024

By Alex Sirois, InvestorPlace Contributor Jan 16, 2024

Mid-cap stocks are expected to have a breakout year especially in light of their underperformance in 2023 with these equities looking strong.

The 3 Best Growth Stocks to Buy in January 2024

By Charles Munyi, InvestorPlace Contributor Jan 14, 2024

The best growth stocks to buy for 2024 with an impressive growth history and solid long-term tailwinds to support 30% EPS growth.

3 Stocks to Capitalize on the Telehealth Explosion

By Ian Bezek, InvestorPlace Contributor Jan 8, 2024

These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic.

3 Earnings Winners Poised to Outperform the Market

By Rick Orford, InvestorPlace Contributor Nov 9, 2023

Discover three earnings winners that beat estimates and could help you beat the market, too. Which ones will you add to your portfolio?

3 Healthcare Stocks Getting Help From the Aging Population

By Larry Ramer, InvestorPlace Contributor Nov 6, 2023

America's aging population needs chronic conditions treatments, and these healthcare stocks are growing in the quest for healing solutions.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Oct 27, 2023

It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday!

The 7 Best Nasdaq Stocks To Buy Now: October 2023

By Alex Sirois, InvestorPlace Contributor Oct 19, 2023

The best Nasdaq stocks go much deeper than the magnificent 7 and offer surprising stability in addition to broad exposure to AI.

Glucose Game-Changers: 3 Diabetes Stocks to Grab on the Downturn

By Larry Ramer, InvestorPlace Contributor Oct 4, 2023

Diabetes stocks have retreated excessively on the belief that a new weight-loss drug will greatly reduce the number of diabetes patients.

Dexcom Inc (DXCM)

3 Breakthrough Medical Device Stocks to Invest In Now

Have $50K? 7 Stocks to Buy to Retire With $1 Million by 2034

Hype Hazards: 3 Stocks to Steer Clear of on Your Wealth-Building Journey

The 3 Best Diabetes Stocks to Buy in June 2024

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Dexcom Inc (DXCM)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

DXCM Stock Predictions, Articles, and Dexcom Inc News

Subscriber Sign in